Refocus Group, Inc. (RFCS) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Devices 行业. 公司总部位于 Dallas, TX, 美国. 现任CEO为 J. Michael Judy.
RFCS 拥有 IPO日期为 2003-03-07, 4 名全职员工, 在 Other OTC, 市值为 $25.00.
Refocus Group, Inc., a medical device company, engages in the research and development of treatments for human vision disorders, primarily for presbyopia. The company develops VisAbility Micro-Insert System, an investigational medical device that is in clinical trials for use in the binocular presbyopic treatment. It serves patients and eye care professionals. The company was founded in 1994 and is based in Dallas, Texas.
